Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies
Anand Patel(Ascension), Olatoyosi Odenike(University of Chicago), Ellen Madarang(University of Miami), Madelyn Burkart(Atrium Health Wake Forest Baptist), Yasmin Abaza(Northwestern University), Marta Davidson(Princess Margaret Cancer Centre), Joshua Kassner(Memorial Sloan Kettering Cancer Center), John Cursio, Hannah Johnston(University of Illinois Chicago), Timothy S. Oh(Northwestern University), Evan C. Chen(Dana-Farber Cancer Institute), Kristen Pettit(University of Michigan), Terrence Bradley(University of Miami Health System), Vikas Gupta(Indian Institute of Technology Kanpur), Auro Viswabandya(Princess Margaret Cancer Centre), James Yoon(Beth Israel Deaconess Medical Center), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Sunil Iyer(University of Miami), Chandrasekar Muthiah(Medical College of Wisconsin), Rory M. Shallis(Smilow Cancer Hospital), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Raven Dean(University of Chicago), Guru Subramanian Guru Murthy(Medical College of Wisconsin)
Cited by 1
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304